Khaled M. Elokely

According to our database, Khaled M. Elokely authored at least 5 papers between 2013 and 2026.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2026

Defining the Data set Defines the QSAR Claim.

Manal A. Nael, Laxman M. Alakonda, Khaled M. Elokely

J. Chem. Inf. Model., 2026

2021

Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment.

Anjela Manandhar, Vunnam Srinivasulu, Mohamad Hamad, Hamadeh Tarazi, Hany Omar, Dennis J. Colussi, John Gordon, Wayne Childers, Michael L. Klein, Taleb H. Al-Tel, Magid Abou-Gharbia, Khaled M. Elokely

J. Chem. Inf. Model., 2021

Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening.

Anjela Manandhar, Benjamin E. Blass, Dennis J. Colussi, Imane Almi, Magid Abou-Gharbia, Michael L. Klein, Khaled M. Elokely

J. Chem. Inf. Model., 2021

2013

Docking Challenge: Protein Sampling and Molecular Docking Performance.

Khaled M. Elokely, Robert J. Doerksen

J. Chem. Inf. Model., 2013

Drug activity prediction using multiple-instance learning via joint instance and feature selection.

Zhendong Zhao, Gang Fu, Sheng Liu, Khaled M. Elokely, Robert J. Doerksen, Yixin Chen, Dawn Wilkins

BMC Bioinform., 2013